共 50 条
- [41] Phase 2 single-arm study of irinotecan in combination with temozolomide in children with recurrent or refractory medulloblastoma and in children with newly diagnosed high-grade gliomaNEURO-ONCOLOGY, 2008, 10 (03) : 511 - 512Hargrave, DarrenGeoerger, BirgitCisar, LauraBreazna, AuroraTroy, NicoleDorman, AndrewElliott, MartinFrappaz, DidierMadero, LuisPerek, DanutaRialland, XavierSanchez-Codina, JiosepeGrill, Jacques
- [42] Tramadol/Acetaminophen Combination Tablets in Cancer Patients with Chemotherapy-Induced Peripheral Neuropathy: A Single-Arm Phase II StudyPALLIATIVE MEDICINE REPORTS, 2020, 1 (01): : 25 - 31Naruge, DaisukeNagashima, FumioKawai, KirioOkano, NaohiroKobayashi, TakaakiFuruse, Junji
- [43] PHASE 2 STUDY OF CAPECITABINE AND IRINOTECAN COMBINATION CHEMOTHERAPY (MODIFIED XELIRI REGIMEN) IN PATIENTS WITH ADVANCED GASTRIC CANCER (CHINA)JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2011, 41 (03) : I9 - I10Luo, H. Y.Wang, Z. Q.Wang, F. H.Qiu, M. Z.Teng, K. Y.Ruan, D. Y.He, Y. J.Li, Y. H.Xu, R. H.
- [44] AGIG Chemo-Immunotherapy in Patients With Advanced Pancreatic Cancer: A Single-Arm, Single-Center, Phase 2 StudyFRONTIERS IN ONCOLOGY, 2021, 11Dai, WangshuQiu, XinLu, ChangchangZou, ZhengyunSha, HuiziKong, WeiweiLiu, BaoruiDu, Juan
- [45] Phase Ib/II combination study of APR-246 and azacitidine (AZA) in patients with TP53 mutant myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML)CANCER RESEARCH, 2018, 78 (13)Sallman, David A.DeZern, AmySweet, KendraSteensma, David P.Cluzeau, ThomasSekeres, MikkaelGarcia-Manero, GuillermoRoboz, GailMcLemore, AmyMcGraw, KathyPuskas, JohnZhang, LingBhagat, ChiragGraber, ArminAl Ali, Najla H.Padron, EricTell, RogerLancet, Jeffrey E.Fenaux, PierreList, Alan F.Komrokji, Rami S.
- [46] Neoadjuvant Toripalimab Combination in Patients with Stage IIB-IIIB NSCLC: A Single-Arm, Phase 2 Trial (Renaissance Study)JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S288 - S289Yan, S.Chen, J.Wang, J.Lv, C.Bi, J.Yang, X.Li, S.Wang, Y.Li, X.Yang, Y.Wu, N.
- [47] Phase I study of DKN-01, an anti-DKK1 antibody, in combination with paclitaxel (pac) in patients (pts) with DKK1+relapsed or refractory esophageal cancer (EC) or gastro-esophageal junction tumors (GEJ).JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)Bendell, Johanna C.Murphy, Janet E.Mahalingam, DevalingamHalmos, BalazsSirard, Cynthia A.Landau, Steven B.Ryan, David P.
- [48] The biomarker TP53 divides patients with neoadjuvantly treated esophageal cancer into 2 subgroups with markedly different outcomes. A p53 Research Group studyJOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2014, 148 (05): : 2280 - 2286Kandioler, DanielaSchoppmann, Sebastian F.Zwrtek, RonaldKappel, SonjaWolf, BrigitteMittlboeck, MartinaKuehrer, IreneHejna, MichaelPluschnig, UrsulaBa-Ssalamah, AhmedWrba, FritzZacherl, Johannes
- [49] Perioperative toripalimab and chemotherapy in locally advanced gastric or gastro-esophageal junction cancer: a randomized phase 2 trial (Jan, 10.1038/s41591-023-02721-w, 2024)NATURE MEDICINE, 2024, 30 (2) : 605 - 605Yuan, Shu-QiangNie, Run-CongJin, YingLiang, Cheng-CaiLi, Yuan-FangJian, RuiSun, Xiao-WeiChen, Ying-BoGuan, Wen-LongWang, Zi-XianQiu, Hai-BoWang, WeiChen, ShiZhang, Dong-ShengLing, Yi-HongXi, Shao-YanCai, Mu-YanHuang, Chun-YuYang, Qiu-XiaLiu, Zhi-MinGuan, Yuan-XiangChen, Yong-MingLi, Ji-BinTang, Xiong-WenPeng, Jun-ShengZhou, Zhi-WeiXu, Rui-HuaWang, Feng
- [50] CARMEN-GC01: Phase II, open-label, single-arm study of tusamitamab ravtansine in combination with ramucirumab in pretreated patients with gastric or gastroesophageal junction adenocarcinoma (GA/GEJA)ANNALS OF ONCOLOGY, 2022, 33 (07) : S1124 - S1124Esposito, F. M.Lee, J.Rha, S. Y.Penkov, K. D.Moisseev, A.Van den Eynde, M.Prenen, H.Garcia, M. DiezGumus, M.Sagawa, T.Nechaeva, M.Kajiwara, T.Harputluoglu, H.Charbonnier, L.Bensfia, S.Yang, N.Oh, D-Y.